Clinical trial
Evaluation of Single Dose and Steady State Pharmacokinetics of Flibanserin Postmenopausal Women With Hypoactive Sexual Desire Disorder
NCT01188603 is registered in ClinicalTrials.gov with Sprout Pharmaceuticals, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Single Dose and Steady State Pharmacokinetics of Flibanserin Postmenopausal Women With Hypoactive Sexual Desire Disorder
- Lead sponsor
- Sprout Pharmaceuticals, Inc
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2010
- Completion date
- October 31, 2010
- Enrollment
- 24 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.